leisure time -WSS

leisure time

author：Wikipedia 2025-09-30 12:18:14 - browse：3

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： 'Ancient DNA,' 23andMe reveal African American ancestries

entertainment

WSS

CDC: Cases of alpha

What Henrietta Lacks settlement says about racism in medicine

The drug industry sees a key ally in the Senate prevail

VC firm RA Capital starts a new synthetic biology incubator

Marc Tessier

Behind warning on Apellis’s eye drug lies a conflict of interest

knowledge

leisure time

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

What Mike Pence has said that could be used in a Donald Trump trial

What does generative AI mean for health care? We asked experts

White House drug shortage group privately met with industry

Hollywood unions extend contract negotiations for actors

White House drug shortage group privately met with industry

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

In Memoriam: Notable people who died in 2023

CDC: Cases of alpha

leisure time

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

For BCIs, commercial hurdles may be bigger than scientific ones

Verily hires former Apple Health leader as chief scientific officer

Biden jokes that Republicans may impeach him because inflation is starting to cool down

Biden jokes that Republicans may impeach him because inflation is starting to cool down

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

focus

focus

entertainment

hotspot